DAF-2

The founding longevity gene of modern aging research. DAF-2 is the sole C. elegans receptor for insulin-like peptides — the single ancestral gene that vertebrates expanded into multiple paralogs, principally INSR (insulin receptor) and IGF1R (IGF-1 receptor); DAF-2 is equally distant from all three vertebrate insulin receptor superfamily members ¹. Loss-of-function mutations in daf-2 extend adult C. elegans lifespan approximately 2-fold — a finding reported by Kenyon, Chang, Gensch, Rudner, and Tabtiang in 1993 ² that proved aging is under genetic regulation and launched the modern era of longevity biology. The longevity phenotype is completely suppressed by simultaneous loss of daf-16, the worm FOXO transcription factor, establishing the IIS → DAF-16 axis as the core transcriptional longevity program ².

Historical significance — the 1993 paper

Kenyon et al. 1993 (Nature 366:461) is one of the most consequential papers in biogerontology. Prior to this work, the prevailing view held that aging was not genetically regulated in a meaningful sense — it was a passive accumulation of stochastic damage, not subject to Darwinian tuning via single genes. The daf-2(e1370) loss-of-function result — that mutating a single gene could double an animal’s lifespan — demonstrated unambiguously that longevity is genetically programmable. The paper’s further finding that daf-16 loss of function suppresses the daf-2 lifespan extension established the first longevity epistasis hierarchy and seeded a decades-long research program into IIS-FOXO signaling across species ³.

Every major thread in modern longevity genetics — Drosophila dFOXO, mammalian Igf1r+/- mice (see igf1r), FOXO3A association with human longevity (see foxo3), IGF-1 levels in centenarians — traces conceptually back to the 1993 daf-2 paper.

Identity

• UniProt: Q968Y9 (DAF-2, C. elegans insulin-like receptor; Swiss-Prot reviewed). Note: accession Q967D7 is a Drosophila protein (Turtle/TUTL) — not DAF-2.
• NCBI Gene: 175410; WormBase locus tag CELE_Y55D5A.5 (isoform a: Y55D5A.5a, isoform c: Y55D5A.5c)
• WormBase: WBGene00000898
• HGNC: null — worm gene; no human HGNC entry
• GenAge: not independently listed in GenAge-human; the daf-2 longevity phenotype is captured via the IIS pathway entry and via daf-16 (the effector). needs-canonical-id — verify GenAge-models entry number.
• Mammalian orthologs: INSR (insulin receptor) + IGF1R (IGF-1 receptor) + insulin receptor-related receptor — DAF-2 is the single ancestral receptor that vertebrates expanded and diverged into these paralogs. Kimura 1997 reports DAF-2 is equally distant from all three (35%, 34%, 33% identity respectively), suggesting DAF-2 is the ancestor of the entire subfamily ¹. This is a critical structural difference: vertebrates separate insulin and IGF-1 sensing into distinct receptors; C. elegans integrates both signals through one receptor ¹.
• Protein length: 1,846 amino acids (canonical isoform; UniProt Q968Y9, Swiss-Prot reviewed, confirmed 2026-05-04). The cDNA open reading frame is 5,538 bases ¹. Alternative isoforms exist (WormBase Y55D5A.5c, 1,770 aa, unreviewed).

Domain organization

DAF-2 is a receptor tyrosine kinase in the insulin/IGF-1 receptor superfamily. Like vertebrate INSR and IGF1R, DAF-2 is believed to form an α₂β₂ heterotetrameric receptor complex, though the precise disulfide-bonded architecture has not been solved to atomic resolution in C. elegans.

Subunit / region	Notes
Signal peptide	N-terminal; cleaved in mature protein
α-subunit (extracellular)	Ligand-binding; cysteine-rich domains; disulfide-linked to β-subunit
Furin cleavage site	α–β junction; processed in trans-Golgi analogous to vertebrate INSR
β-subunit transmembrane helix	Single-pass; anchors receptor in plasma membrane
Juxtamembrane region	Regulatory; contains key regulatory phosphosites in vertebrate orthologs
Tyrosine kinase domain	Intracellular; activation-loop Tyr analogous to vertebrate INSR Tyr1158/1162/1163; primary signaling domain
C-terminal regulatory region	Substrate-docking; connects to IRS-domain scaffold proteins

The structural homology to vertebrate insulin/IGF receptors was established by Kimura et al. 1997, who cloned daf-2 and showed it encodes an insulin receptor family member ¹. Key quantitative domain homologies from Kimura 1997: ligand-binding domain ~36% identical to insulin receptor (35% to IGF-I receptor); Cys-rich region 34% identical to insulin receptor (28% to IGF-I receptor); the 275-amino acid tyrosine kinase domain is 70% similar and 50% identical to the human insulin receptor kinase domain ¹. This defined the molecular basis for why daf-2 LoF phenocopies aspects of reduced insulin/IGF-1 signaling in mammals.

Insulin-like ligand repertoire (37 INS peptides per Pierce 2001)

Unlike vertebrates — which have a small, clearly defined set of insulin-related hormones — C. elegans encodes 37 insulin-like (ins) gene products (ins-1 through ins-37), identified by systematic genome analysis ⁴. These fall into functional classes with respect to DAF-2:

• Agonists — activate DAF-2; promote DAF-16 phosphorylation and cytoplasmic retention; suppress longevity program. Of five ins genes tested in Pierce 2001, four without a predicted C peptide did not antagonize DAF-2. DAF-28 is a well-characterized agonist described in other work; daf-28 LoF partially extends lifespan (not from Pierce 2001 — attribution note: DAF-28 characterization is from Li et al. 2003 and Murphy et al. 2003).
• Antagonists — overexpression enhances dauer arrest in daf-2 mutant backgrounds, indicating competition with endogenous agonist signaling. INS-1 (the closest structural homolog to vertebrate insulin; 32% identity over B and A chains) and INS-18 (the only other ins gene tested with a predicted C peptide) are established DAF-2 antagonists; high gene dosage of either enhances dauer arrest in daf-2(e1365) and wild-type backgrounds at 26°C ⁴. The ins-1 deletion mutant (nr2091) alone shows no phenotype, indicating functional redundancy among the 37 ins genes ⁴.

The large, redundant ins gene family creates a buffering system: single deletion of most ins genes produces no phenotype, and the net balance of agonist vs antagonist ins signaling in different tissues likely contributes to tissue-specific aging rates and environmental sensing (food availability, temperature, pheromone cues) ⁴. needs-replication — the full agonist/antagonist classification of all 37 ins peptides is not complete; Pierce 2001 functionally tested only five.

The IIS pathway downstream of DAF-2

DAF-2 activates the canonical insulin/IGF-1 signaling (IIS) cascade:

DAF-2 (activated by agonist ins peptides, e.g. DAF-28)
  → AGE-1 (PI3K catalytic subunit; C. elegans PI3K ortholog)
  → PIP3 production
  → PDK-1 (phosphoinositide-dependent kinase) recruitment
  → AKT-1 / AKT-2 / SGK-1 activation
  → DAF-16 phosphorylation (Thr273/Ser319 and analogous sites)
  → 14-3-3 binding → DAF-16 cytoplasmic retention → INACTIVE

When DAF-2 signaling is reduced (by LoF mutation, antagonist ins peptides, or food restriction):

Low DAF-2 activity → Low AGE-1 → Low PIP3
  → AKT-1/AKT-2 inactive → DAF-16 unphosphorylated
  → DAF-16 nuclear import
  → Longevity gene activation (sod-3, hsp-12.6, mtl-1, lys-7,...)
  → Stress resistance, extended lifespan

The downstream pathway, key interactors (AGE-1, PDK-1, AKT-1, AKT-2, SGK-1), and DAF-16 target gene program are detailed on the daf-16 page.

daf-2 alleles and the two-class system

Gems et al. 1998 conducted detailed phenotypic analysis of 16 alleles (15 temperature-sensitive + 1 nonconditional e979/e286), plus 2 deficiency alleles (mDf11, mDf12), identifying two overlapping pleiotropic classes of daf-2 mutation ⁵. All 15 ts alleles increase adult lifespan; the greatest increases in maximum lifespan were approximately 3-fold (300% of N2 wild type) ⁵:

Feature	Class I	Class II
Representative alleles	e1368, e1371, sa193 (Class 1A); m41 (Class 1B); e1365, e1369, m577 (Class 1C); m212 (Class 1D)	m596 (2A); m120, m579 (2B); e1370 (2C); e979, e1391 (2D); sa223 (2E)
Constitutive dauer formation (Daf-c)	Yes	Yes
Lifespan extension	Yes (up to ~3× maximum at 15°)	Yes (up to ~3× maximum at 15°; but median lifespan extension often similar to or less than Class I at 22.5°)
Unfertilized oocyte production (>6%) at 25.5°	Low (< 6% for most)	Higher (> 6% for Class 2C–2E)
Adult motility defects (Unc)	Absent or late-onset	Present (variable by subclass)
Gonad morphology defects	Absent or mild	Present (Class 2C–2E)
Brood size reduction	Mild (60–100% N2)	More severe (< 60% N2 for Class 2C–2E)
Internal hatching > 20% at 22.5°	No	Yes (Class 2C–2E)
Late progeny production	No	Yes (Classes 2B–2E)
Embryonic/L1 arrest at 25.5°	Low (< 6%)	Higher (11–100% for Classes 2D–2E)

Practical implication: The canonical allele used in most longevity studies — daf-2(e1370) — is a Class 2C allele. Its pleiotropic phenotypes (Unc motility, gonad abnormalities, brood size reduction < 60% N2, > 20% internal hatching at 22.5°, late progeny production) complicate interpretation of longevity assays. The reduction in median relative to maximum lifespan for e1370 at 22.5° reflects these additional defects. Cleaner longevity phenotypes with less reproductive and motility confounding are seen in Class 1 alleles ⁵.

Both classes are suppressed by daf-16 LoF, confirming that DAF-16 is the essential longevity effector regardless of allele class ².

Lifespan extension and epistasis

Primary finding: daf-2(e1370) extends C. elegans adult lifespan approximately 2-fold compared to wild-type N2 worms, the largest single-gene longevity extension known at the time of the 1993 paper ². no-fulltext-access — Kenyon 1993 is closed-access; the exact n values, lifespan curves, and statistical tests cited here cannot be verified from a local PDF.

Epistasis with daf-16: Simultaneous LoF of daf-16 completely suppresses daf-2 longevity — daf-2;daf-16 double mutants live no longer than wild-type worms ². This demonstrated that DAF-16 is the essential downstream effector of daf-2-dependent longevity, not merely one of several parallel effectors.

Epistasis with age-1: age-1 (PI3K/AGE-1) LoF also extends lifespan; this extension is likewise daf-16-dependent ¹. daf-2 and age-1 LoF are broadly epistatic (both act through the same pathway), confirming the linear DAF-2 → AGE-1 → DAF-16 axis.

Epistasis with hsf-1: HSF-1 (heat-shock factor 1) and DAF-16 cooperate downstream of daf-2 LoF; simultaneous knockdown of both hsf-1 and daf-16 further reduces lifespan in daf-2 mutants beyond either single knockdown alone — suggesting partially independent longevity transcriptional programs converge downstream of daf-2 (see daf-16 page, Hsu et al. 2003 section).

Model-organism-to-human extrapolation

Dimension	Status	Notes
Pathway conserved in humans?	yes	INSR + IGF1R are the vertebrate paralogs; PI3K → AKT → FOXO axis highly conserved
Phenotype conserved in humans?	partial	Igf1r+/- mice extend lifespan ~26% (Holzenberger 2003; see igf1r); FOXO3A variants associate with human longevity GWAS (see foxo3); no human equivalent of daf-2 LoF
Replicated in humans?	no	Cannot genetically knock down the insulin/IGF-1 receptor for longevity; observational data only

The quantitative magnitude of effect does not transfer linearly. daf-2 LoF produces ~2-fold lifespan extension in a poikilothermic invertebrate with a 3-week lifespan. In mice, analogous perturbations (Igf1r+/- heterozygosity) yield ~26% extension — a meaningful but far smaller relative effect. In centenarian humans, rare IGF1R variants and FOXO3A SNPs are enriched, but effect sizes are small (OR 2–3× for specific genotypes) ³. This quantitative attenuation from invertebrate to vertebrate is a general feature of the IIS-longevity connection and does not negate the conservation of the pathway logic.

needs-human-replication — No human intervention that specifically targets IIS at the DAF-2/INSR+IGF1R level has been shown to extend human lifespan in an RCT. All causal longevity evidence is from invertebrates and rodents.

Aging context

DAF-2 represents the deregulated-nutrient-sensing hallmark in C. elegans. The connection between insulin/IGF-1 signaling intensity and lifespan reflects evolutionary logic: during periods of food abundance, high IIS promotes growth, reproduction, and somatic maintenance investment in the reproductive program; during scarcity, low IIS redirects resources to stress resistance, fat storage, and longevity programs (including dauer larva entry) ³. daf-2 LoF mimics chronic low-nutrient-sensing signaling, engaging the longevity program constitutively.

The DAF-2/IIS axis is the best-established mechanistic bridge between nutrient sensing and aging:

1. Direct genetic evidence — single-gene LoF doubles lifespan ²
2. Downstream mechanism identified — DAF-16 nuclear localization as the key transcriptional switch ²
3. Conserved across species — worm → fly → mouse → human GWAS ³
4. Pharmacologically tractable — mTOR and IIS pathways share several targets (rapamycin, metformin) under clinical investigation (see mtor, metformin)

Pathway membership

• insulin-igf1 — DAF-2 is the receptor node at the top of the worm IIS cascade; the pathway page describes the full signal flow
• deregulated-nutrient-sensing — hallmark mechanistic basis; DAF-2 activity level encodes nutrient status
• ampk — parallel longevity pathway; AAK-2 (AMPK) and DAF-16 operate in parallel downstream of DAF-2 (see daf-16 page, Apfeld 2004 section)

Nomenclature note

The gene name daf-2 derives from “Dabnormal D****Auer Formation” — daf-2 was initially identified as a gene whose LoF causes constitutive dauer larva formation regardless of environmental conditions. The dauer larva is a long-lived, stress-resistant, non-feeding larval diapause state induced by starvation or overcrowding. The realization that the same gene controlling dauer entry also controls adult lifespan was the conceptual breakthrough: the dauer and adult longevity programs share a common IIS-dependent upstream regulator. See caenorhabditis-elegans for dauer biology.

Related pages

• daf-16 — primary downstream effector; daf-16 LoF fully suppresses daf-2 longevity; single ancestral FOXO
• age-1 — PI3K catalytic subunit; immediately downstream of DAF-2
• insr — vertebrate insulin receptor; one of two paralogs derived from the DAF-2 ancestor
• igf1r — vertebrate IGF-1 receptor; second vertebrate paralog; Igf1r+/- mouse lifespan extension (Holzenberger 2003) directly inspired by the daf-2 paradigm
• foxo3 — primary mammalian DAF-16 ortholog; FOXO3A GWAS human longevity associations
• akt — AKT1/2 human ortholog of AKT-1/AKT-2; phosphorylates FOXO in mammals
• insulin-igf1 — pathway page for the IIS cascade in aging
• caenorhabditis-elegans — model organism; dauer biology and worm aging context
• foxo1 — second mammalian FOXO ortholog; hepatic insulin signaling

Gaps and limitations

• no-fulltext-access — Kenyon 1993 (10.1038/366461a0) is closed-access; key founding-paper quantitative claims (exact n, survival curve numbers, daf-16 epistasis statistics) cannot be verified from local PDF.
• needs-canonical-id — GenAge-models entry number for daf-2 not confirmed; search GenAge at genomics.senescence.info/genes/models.php.
• needs-replication — Full agonist/antagonist classification of all 37 ins peptides is incomplete; Pierce 2001 functionally tested only five; functional data from additional ins genes comes from other work (Kawano 2000, Li 2003, Murphy 2003, etc.).
• needs-human-replication — All causal longevity evidence is from invertebrates (and partial mammalian model organisms); no human LoF equivalent of daf-2 has been studied.
• no-mechanism — The atomic-resolution structure of the DAF-2 extracellular ligand-binding domain in complex with an ins peptide ligand has not been solved; structural basis for agonist vs antagonist discrimination is not established.
• long-term-unknown — The relative contributions of different tissues (neurons, intestine, hypodermis, muscle) to daf-2-mediated lifespan extension are established at the level of tissue-specific rescue experiments but are not quantitatively partitioned across the 37 ins peptide inputs.

Footnotes

Footnotes

1. doi:10.1126/science.277.5328.942 · Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G · Science 277:942 (1997) · in-vivo + molecular cloning (C. elegans) · cloned daf-2; confirmed as sole insulin receptor family member in C. elegans genome; DAF-2 35% identical to human INSR, 34% to IGF-IR, 33% to insulin receptor-related receptor; kinase domain 275 aa, 50% identical/70% similar to human INSR kinase; cDNA ORF 5,538 bases; DAF-2 is proposed ancestor of all three vertebrate paralogs · model: C. elegans N2 + mutant alleles · local PDF verified ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷

2. doi:10.1038/366461a0 · Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R · in-vivo (C. elegans) · daf-2(e1370) LoF approximately doubles adult lifespan vs N2 wild-type; daf-16 LoF completely suppresses longevity extension; founding paper of modern aging genetics · model: C. elegans N2 and mutant strains · not_oa no-fulltext-access ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷

3. doi:10.1038/nature08980 · Kenyon CJ · review (Nature) · comprehensive review of IIS-FOXO axis across species; DAF-16 target genes; quantitative attenuation from worm to mouse to human; mammalian extrapolation framework · local PDF available ↩ ↩² ↩³ ↩⁴

4. doi:10.1101/gad.867301 · Pierce SB, Costa M, Wisotzkey R, Devadhar S, Homburger SA, Buchman AR, Ferguson KC, Heller J, Platt DM, Pasquinelli AA, Liu LX, Doberstein SK, Ruvkun G · Genes Dev 15:672 (2001) · in-vivo + molecular (C. elegans) · identified 37 ins gene family members (ins-1 through ins-37) by systematic genome search; INS-1 (closest to vertebrate insulin, 32% B+A chain identity) and INS-18 are DAF-2 antagonists — overexpression enhances dauer arrest in daf-2 and wild-type backgrounds; human insulin also antagonizes DAF-2 signaling; only ins genes with predicted C peptide (INS-1, INS-18) antagonize DAF-2; ins-1 deletion (nr2091) has no phenotype alone (functional redundancy); ins-1 wild-type life span unaffected by deletion · model: C. elegans · local PDF verified (downloaded 2026-05-04) ↩ ↩² ↩³ ↩⁴

5. doi:10.1093/genetics/150.1.129 · Gems D, Sutton AJ, Sundermeyer ML, Albert PS, King KV, Edgley ML, Larsen PL, Riddle DL · Genetics 150:129 (1998) · in-vivo (C. elegans) · detailed phenotypic characterization of 16 daf-2 alleles (15 ts + 1 nonconditional e979); two pleiotropic classes defined — Class 1 (Daf-c, Age, Itt; low embryonic arrest, mild reproductive defects) and Class 2 (all Class 1 traits plus Unc motility, gonad abnormalities, severe brood reduction, internal hatching > 20%, late progeny); greatest lifespan extension ~3-fold maximum at 15°; e1370 is Class 2C · model: C. elegans · local PDF verified (downloaded 2026-05-04) ↩ ↩² ↩³